June 13, 2018 marks the 5th anniversary of the landmark U.S. Supreme Court ruling that overturned Myriad Genetics’ patents on what are popularly known as the “breast cancer genes," genes linked to increased cancer risk in some families.
Find out what’s happened in the five years since the Supreme Court overturned the company’s monopoly on BRCA genetic testing risk.
Our featured speakers are ACLU staff attorney Sandra Park, JD, one of the lead attorneys in the case, and Tania Simoncelli, MS, director of policy for science at the Chan Zuckerberg Initiative, who heralded the original case as the ACLU’s Science Advisor.
